international_prognostic_index_chronic_lymphocytic_leukemia v.0
International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) stratifies patients with chronic lymphocytic leukemia into four risk categories.
To stratify patients with chronic lymphocytic leukemia into four risk categories: low risk, intermediate risk, high risk and very high risk group.
CLL-IPI Score is calculated from 5 parameters: Age, Clinical stage, Serum β2 microglobulin, IGHV mutational status and TP53 status. Interpretation: CLL-IPI Score Risk 5-year survival 0-1 Low risk 93.2% 2-3 Intermediate risk 79.3% 4-6 High risk 63.3% 7-10 Very high risk 23.3%
1. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. Lancet Oncol. 2016;17(6):779-90.
OBSERVATION.basic_demographic.v1, OBSERVATION.lab_test_serum_b2_microglobulin.v0, EVALUATION.international_prognostic_index_chronic_lymphocytic_leukemia.v0
